GlassScriptPhysician profile
Lucy A Buchert
NPI 1306821145
$1,704.51
in general payments reported to CMS, 2019-2025
17 companies · $70.83 in 2025
The $70.83 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $85.36 · 2022: $451 · 2023: $638 · 2024: $459 · 2025: $70.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,168.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $339.05 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $335.58 | 2021-2024 | Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $254.33 | 2022-2024 | Breztri, Andexxa |
| Abbott Laboratories | $225.53 | 2023 | Proclaim, Eterna |
| Merck Sharp & Dohme LLC | $129.20 | 2021-2024 | Gardasil 9, Gardasil, Capvaxive |
| Novartis Pharmaceuticals Corporation | $92.42 | 2022 | |
| Pfizer INC. | $70.58 | 2023-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $62.40 | 2022 | |
| Amgen INC. | $51.42 | 2024-2025 | Evenity, Prolia |
| Abbvie INC. | $25.57 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.48 | 2022 | |
| Sanofi Pasteur INC. | $20.46 | 2022 | |
| Biogen, INC. | $19.88 | 2024 | Spinraza |
| Mannkind Corporation | $15.25 | 2023 | Afrezza |
| Organon LLC | $13.81 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $13.53 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $13.02 | 2023 | Uptravi, Opsumit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucy Buchert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.